- Activities for the Development of Targeted Radionuclide Therapy in Japan
-
Kinuya S
- KMID: 2446882
- Nucl Med Mol Imaging.
- 2019 Feb;53(1):35-37.
- doi: 10.1007/s13139-018-0563-4
Targeted radionuclide therapy (TRT) is unique because of its efficacy and its theranostic feature in the era of precision medicine. So far, introduction of new TRT has not been going... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Consensus on I-131 MIBG Therapy
-
Kayano D, Kinuya S
- KMID: 2418989
- Nucl Med Mol Imaging.
- 2018 Aug;52(4):254-265.
- doi: 10.1007/s13139-018-0523-z
Metaiodobenzylguanidine (MIBG) is structurally similar to the neurotransmitter norepinephrine and specifically targets neuroendocrine cells including some neuroendocrine tumors. Iodine-131 (I-131)-labeled MIBG (I-131 MIBG) therapy for neuroendocrine tumors has been performed... -
- CITED
-
- Close
- SHARE
-
- Close
